SIK3 and skeletal dysplasia: A homozygous mutation in the catalytic domain of SIK3 (Arg187Cys, rs1565460853) impairs SIK3 activity and leads to skeletal dysplasia by altering mTOR activity downstream of the PTH/PTH-related protein signaling during skeletogenesis (61).